Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 15, 2019
Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?Hanan Goldberg, Douglas C Cheung, Thenappan Chandrasekar, et al.
European Urology Open Science|August 2, 2021
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological OutcomesYazan Qaoud, Piero Bettoli, Noelia Sanmamed-Salgado, et al.
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Utility of digital rectal examination in a population with prostate cancer treated with active surveillanceJaime O Herrera-Caceres, Marian S Wettstein, Hanan Goldberg, et al.
Journal of the National Cancer Institute|July 13, 2013
Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 8, 2025
Corrigendum to "Magnetic Resonance Imaging (MRI)-Adapted Prostate Cancer Risk Tool Incorporating Cribriform and Intraductal Carcinoma" (Modern Pathology 2025 Dec;38(12):100852)Ngoc-Nhu Jennifer Nguyen, Kristen Liu, Katherine Lajkosz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2025
Magnetic Resonance Imaging (MRI)-Adapted Prostate Cancer Risk Tool Incorporating Cribriform and Intraductal CarcinomaNgoc-Nhu Jennifer Nguyen, Kristen Liu, Katherine Lajkosz, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Clinical Epigenetics|November 25, 2018
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancerFang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, et al.
BMC Cancer|July 17, 2016
Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicineNazleen C Lobo, Craig Gedye, Anthony J Apostoli, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 15, 2019
Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?Hanan Goldberg, Douglas C Cheung, Thenappan Chandrasekar, et al.
European Urology Open Science|August 2, 2021
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological OutcomesYazan Qaoud, Piero Bettoli, Noelia Sanmamed-Salgado, et al.
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Utility of digital rectal examination in a population with prostate cancer treated with active surveillanceJaime O Herrera-Caceres, Marian S Wettstein, Hanan Goldberg, et al.
Journal of the National Cancer Institute|July 13, 2013
Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 8, 2025
Corrigendum to "Magnetic Resonance Imaging (MRI)-Adapted Prostate Cancer Risk Tool Incorporating Cribriform and Intraductal Carcinoma" (Modern Pathology 2025 Dec;38(12):100852)Ngoc-Nhu Jennifer Nguyen, Kristen Liu, Katherine Lajkosz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2025
Magnetic Resonance Imaging (MRI)-Adapted Prostate Cancer Risk Tool Incorporating Cribriform and Intraductal CarcinomaNgoc-Nhu Jennifer Nguyen, Kristen Liu, Katherine Lajkosz, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Clinical Epigenetics|November 25, 2018
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancerFang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, et al.
BMC Cancer|July 17, 2016
Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicineNazleen C Lobo, Craig Gedye, Anthony J Apostoli, et al.
Pageof 27